Newsroom

Lucerno Dynamics Announces New Business Relationship with Siemens Healthineers

Lucerno has entered into a Master Resellers Agreement to add its Lara® System to the Siemens Healthineers portfolio of medical imaging products. With this agreement, Siemens Healthineers becomes Lucerno’s first United States partner reseller and makes the Lara® System available to nuclear medicine customers nationwide. Press Release

Free AltusLearn Webinar

Dr. David Townsend, the co-inventor of PET/CT scanner, Dr. Jackson Kiser, Medical Director of Molecular Imaging at Carilion Clinic, Dr. Darrell Fisher, nuclear medicine physicist, past president Health Physics Society, and previous member of the NRC’s Advisory Committee on the Medical Uses of Isotopes (ACMUI), Dr. Marjan Boerma, the director of the UAMS Division of Radiation Health, and others shared research on extravasations. You can watch the webinar and earn 1 CE credit here.

Findings: Unintentional exposure poses risk to nuclear medicine patients

Lucerno highlighted a peer-reviewed publication in the radiation safety journal Health Physics demonstrating that extravasations of routinely-used radiopharmaceuticals can cause unintended irradiation to patient tissue that “exceed well-established radiation protection and regulatory limits.” Press Release

2021 Omnibus Includes Nuclear Medicine Patient Safety, Transparency Provisions

Lucerno announced that the Fiscal Year 2021 Omnibus Appropriations Act includes critical language to protect the safety of nuclear medicine patients and enhance transparency within the American healthcare system. Press Release

2021 Appropriations Bills Enhance Nuclear Medicine Patient Safety, Transparency

Lucerno announced that Fiscal Year 2021 bills advanced this week by the House Appropriations Committee to the House floor include critical language to protect the safety of nuclear medicine patients and enhance transparency within the American healthcare system. Press Release

Petition for Rulemaking Calls on NRC to Prioritize Patient Safety, Transparency

Lucerno submitted a formal petition for rulemaking to the U.S. Nuclear Regulatory Commission, which calls on the agency to update a 1980 policy that allows nuclear medicine injection errors to remain hidden from patients, treating physicians, and NRC itself. Press Release

Hospitals shouldn’t be exempt from reporting faulty radioisotope injections

“…NRC is now re-evaluating the loophole that allows significant infiltrations to go unreported. Requiring reporting would be a small step for hospitals to implement but a big step toward improving patient care.” Full Text

Lucerno Dynamics Delivers Quality Control Solution for Nuclear Medicine Injections

North Carolina Biotechnology Center publishes an interview with Ron Lattanze, CEO of Lucerno Dynamics.

39 States Call on NRC to Update Nuclear Medicine Safety Policy

The Organization of Agreement States (OAS) – 39 states that work with the U.S. Nuclear Regulatory Commission (NRC) to regulate medical use of radioactive material – has called on NRC to update a 1980 policy that allows nuclear medicine injection errors (extravasations) to remain hidden from patients, treating physicians, and NRC itself. Press Release

Why Quality Matters to Quantification: The Case for Monitoring Radiotracer Injections

The Society of Nuclear Medicine and Molecular Imaging’s Value Initiative highlighted Lara® in its most recent newsletter .

Nuclear Medicine Project: Injection Quality Varies Widely, Can Be Improved

Quality of Resulting PET/CT Image Depends on Center and Technologist Performing Radiopharmaceutical Injection. Press Release

NRC Advisory Committee to Reevaluate 1980 Nuclear Medicine Policy

Policy Exempted Reporting of Flawed Injections of Radiopharmaceuticals. Lucerno Dynamics CEO: Update Policy to Protect Patients, Improve Care, and Prevent. Press Release